LSIF supports subsciption in AcuCort AB

AcuCort AB is currently in the exercise period of the TO 2 warrant program. LSIF has decided to support the subscription by subscribing for 1 MSEK regardless of the share price. Our motivation is that, in our view, the two LOIs – especially the one with Glenmark – are very strong signals that AcuCort is on track. We believe the current share price does not reflect the company's true potential.